TrialDiabetologia2026

A randomised clinical trial testing the safety of and metabolic responses to short-term duodenal infusion of recombinant RORDEP1 in healthy men.

Joachim Gæde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.